Šalis: Australija
kalba: anglų
Šaltinis: APVMA (Australian Pesticides and Veterinary Medicines Authority)
GENTAMICIN SULFATE; CLOTRIMAZOLE; BETAMETHASONE VALERATE
INTERVET AUSTRALIA PTY LIMITED
gentamicin(2640IU/mL)+betamethasone as valerate(0.88mg/mL) + others
TOPICAL CREAM, OINTMENT, PASTE, GEL, LOTION
GENTAMICIN SULFATE ANTIBIOTIC Active 2640.0 IU/ml; CLOTRIMAZOLE IMIDAZOLE Active 8.8 mg/ml; BETAMETHASONE VALERATE STEROID-GLUCOCORTICOID Active 1.07 mg/ml
!12x7.5g; !tubes; *12x15g; *tubes; 12x14mLbot; 12x17mL; 14mL bot; 15g tube; 17mL; 240mL bot; 34mL bot; 6x34mL bot; 7.5g tubes
VM - Veterinary Medicine
INTERVET AUSTRALIA
DOG | BITCH | CASTRATE | PUPPY
EAR,NOSE,THROAT + DERMAL
OTITIS EXTERNA | ACUTE CANINE OTITIS | ASSOCIATED WITH YEAST &/OR BAC | CHRONIC CANINE OTITIS | MALASSEZIA PACHYDERMATIS | OTITIS (CANINE)
Poison schedule: 4; Withholding period: WHP: N/A; Host/pest details: DOG: [OTITIS EXTERNA]; For the treatment of canine acute and chronic otitis externa associated with yeast (Malassezia pachydermatis) and/or bacteria susceptible to gentamicin.DO NOT use in animals with known perforation of the eardrum (tympanic membrane). DO NOT use in pregnant or lactating animals. DO NOT use concomitantly with drugs known to induce ototoxicity. NOT FOR USE in food producing animals.
Registered
2023-07-01
Registered Product Name: OTOMAX Ointment Page 1 of 6 Pack Sizes: 7.5g [15g, 14 mL, 34 mL, 240 mL, 12 x 7.5g, 12 x Date (Version Control): 26/09/2013 1 5g, 12 x 14mL, 6 x 34 mL] Description: Primary Carton APVMA: 51104/58945 Panel labels, text above the header and below the footer are not included in this label text. PRESCRIPTION ANIMAL REMEDY KEEP OUT OF REACH OF CHILDREN READ SAFETY DIRECTIONS BEFORE OPENING OR USING FOR ANIMAL TREATMENT ONLY OTOMAX® OINTMENT RLP Approved ACTIVE INGREDIENTS: GENTAMICIN SULFATE equivalent to 2640 IU Gentamicin Base, 1. 07mg BET AM ETHASONE VALERATE equivalent to 0.88 mg Betamethasone and 8.80 mg CLOTRIMAZOLE per ml. For the treatment of canine acute and chronic otitis externa associat ed with yeast (Malassezia pachydermatis) and/or bacteria susceptible to gentamicin. 7. 5g [1 5g,14 mL, 34 mL, 240 mL, 12 x 7. 5g , 12 x 15g, 12 x 14mL, 6 x 34 mL] MSD logo READ THE ENCLOSED LEAFLET BEFORE USING THIS PRODUCT DIRECTIONS FOR USE: Restraint NOT FOR USE in food-producing animals. Contraindications Contraindicated for use in animals with known perforation of the eardrum (tympanic membrane). Contraindicated for use in pregnant or lactating animals. Contraindicated for concomitant use with drugs known to induce ototoxicity. Precautions If hyper-sensitivity to any component occurs, discontinue treatment and institute appropriate therapy. Avoid co ncomitant use of drugs known to induce ototoxicity. Administration of recommended doses beyond 7 days may result in delayed wound healing. Prolo ng ed use or overdosage may produce adverse immun os uppressive effect s. Antibiotic susceptibility of the pathogenic organism(s) should be determined prior to use of this preparation. Dosage and Administration SHAKE WELL BEFORE USE. Th oroughly clean and dry external ear. Rem ove foreign mater ia l, crusted and d ri ed debris etc. with a non-irritating solution. Cl ip excessi ve hair from treatment area. Examine ear ca nal to ensure tympanic membrane is not ruptured. Dogs less th an 15kg: 4 dro ps. Dogs 1 Perskaitykite visą dokumentą
PRODUCT NAME: OTOMAX OINTMENT MATERIAL SAFETY DATA SHEET THIS REVISION ISSUED: AUGUST, 2009 PAGE: 1 OF 5 MATERIAL SAFETY DATA SHEET Issued by: Intervet Australia Pty Limited Phone: 1 800 033 461 (Business Hours) Poisons Information Centre: 13 11 26 from anywhere in Australia, (0800 764 766 in New Zealand) SUBSTANCE: Suspension of ingredients in water. TRADE NAME: OTOMAX OINTMENT RECOMMENDED USE: For the treatment of canine acute and chronic otitis externa associated with yeast and/or bacteria susceptible to gentamicin. APVMA NO: 51104 CREATION DATE: August, 2009 THIS VERSION ISSUED: August, 2009 and is valid for 5 years from this date. STATEMENT OF HAZARDOUS NATURE: THIS PRODUCT IS CLASSIFIED AS: Not classified as hazardous according to the criteria of SWA. Not a Dangerous Good according to the Australian Dangerous Goods (ADG) Code. RISK PHRASES: Not Hazardous - No criteria found. SAFETY PHRASES: S24/25. Avoid contact with skin and eyes. SUSDP CLASSIFICATION: S4 ADG CLASSIFICATION: None allocated. Not a Dangerous Good under the ADG Code. UN NUMBER: None allocated PHYSICAL DESCRIPTION & COLOUR: A white to off white viscous suspension. ODOUR: no data. MAJOR HEALTH HAZARDS: no significant risk factors have been found for this product. This is an antibiotic preparation. Any person with a history of allergies to this class of substances should avoid all contact with this product as it may cause sensitisation. This is a physiologically active product and so contact should be minimised, especially if the user is taking a form of medication, as interactions can sometimes give unexpected and undesired results. INHALATION: SHORT TERM EXPOSURE: Available data indicates that this product is not harmful. In addition product is unlikely to cause any discomfort or irritation. LONG TERM EXPOSURE: No data for health effects associated with long term inhalation. SKIN CONTACT: SHORT TERM EXPOSURE: Available data indicates that this product is not harmful. It should present no hazards in normal use. However product may be mildly irr Perskaitykite visą dokumentą